ASP Isotopes (NASDAQ:ASPI) Sees Strong Trading Volume – What’s Next?

ASP Isotopes Inc. (NASDAQ:ASPI) saw strong trading volume on Thursday . 1,046,112 shares were traded during mid-day trading, a decline of 30% from the previous session’s volume of 1,491,431 shares.The stock last traded at $8.10 and had previously closed at $8.33.

Analyst Ratings Changes

ASPI has been the subject of several research reports. HC Wainwright cut their price objective on ASP Isotopes from $5.50 to $4.50 and set a “buy” rating for the company in a research report on Wednesday, August 7th. Canaccord Genuity Group reissued a “buy” rating and set a $4.50 target price on shares of ASP Isotopes in a research report on Friday, October 18th. Finally, Canaccord Genuity Group assumed coverage on shares of ASP Isotopes in a research report on Friday, October 4th. They set a “buy” rating and a $4.50 target price for the company.

ASP Isotopes Stock Performance

The company has a current ratio of 4.00, a quick ratio of 4.00 and a debt-to-equity ratio of 2.06. The firm has a market capitalization of $554.34 million, a price-to-earnings ratio of -12.21 and a beta of 3.88. The company has a 50-day moving average of $4.24 and a 200-day moving average of $3.65.

ASP Isotopes (NASDAQ:ASPI) last posted its quarterly earnings results on Monday, August 19th. The company reported ($0.24) earnings per share (EPS) for the quarter. The company had revenue of $1.02 million during the quarter. On average, equities research analysts forecast that ASP Isotopes Inc. will post -0.24 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the company. The Manufacturers Life Insurance Company bought a new stake in ASP Isotopes during the 3rd quarter valued at $52,000. Fielder Capital Group LLC acquired a new stake in shares of ASP Isotopes during the 2nd quarter valued at about $55,000. KKM Financial LLC lifted its stake in ASP Isotopes by 66.2% in the third quarter. KKM Financial LLC now owns 22,600 shares of the company’s stock valued at $63,000 after acquiring an additional 9,000 shares during the last quarter. MetLife Investment Management LLC bought a new stake in ASP Isotopes in the third quarter worth approximately $88,000. Finally, Rhumbline Advisers bought a new stake in ASP Isotopes in the second quarter worth $116,000. 16.80% of the stock is owned by institutional investors and hedge funds.

ASP Isotopes Company Profile

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.